1
Dennis D Jamiolkowski, Rao S Bezwada: Hydrogels of absorbable polyoxaesters containing amines or amido groups. Ethicon, Hal B Woodrow, December 23, 1997: US05700583 (169 worldwide citation)

The present invention describes a crosslinked aliphatic polyoxaesters containing amines and/or amido groups and blends thereof with other polymers that may be used to produce surgical devices such as sutures, sutures with attached needles, molded devices, and the like. The crosslinked aliphatic poly ...


2
Angelo G Scopelianos, Steven C Arnold, Rao S Bezwada, Mark B Roller, Shawn T Huxel: Injectable microdipersions for soft tissue repair and augmentation. Ethicon, Hal B Woodrow, March 17, 1998: US05728752 (61 worldwide citation)

The present invention provides injectable, bioabsorbable microdispersions suitable for use as a soft tissue repair or augmentation material in animals comprising a fluid carrier that is a liquid polymer selected from the group consisting of liquid polymers of a plurality of at least two different fi ...


3
Han Cheng Zhang, Bruce E Maryanoff, Hong Ye, Bruce R Conway, Keith Demarest: Substituted pyrrolines as kinase inhibitors. Janssen Pharmaceutica, Gabriel Lopez, Hal B Woodrow, January 17, 2006: US06987110 (44 worldwide citation)

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.


4
Rao S Bezwada: Liquid copolymers of epsilon-caprolactone and lactide. Ethicon, Hal B Woodrow, August 15, 1995: US05442033 (29 worldwide citation)

A copolymer of from in the range of from about 55 to about 70 weight percent lactide and from in the range of from about 45 to about 30 mole percent .epsilon.-caprolactone suitable for use in biomedical applications such as drug delivery, coatings for surgical sutures and needles, and lubricants for ...


5
Fay W Bailey: Process for cleaning polymer processing equipment. Phillips Petroleum Company, Hal B Woodrow, June 13, 1989: US04838948 (20 worldwide citation)

The present invention pertains to a process for cleaning polymeric processing equipment. The process comprises purging the polymer processing equipment with a composition comprising a polymer, a mild abrasive and a sulfonated surfactant.


6
Kevin L Cooper, Angelo G Scopelianos: Copolymers of an aromatic anhydride and aliphatic ester. Ethicon, Hal B Woodrow, June 14, 1994: US05321113 (18 worldwide citation)

A copolymer of an aromatic anhydride and an aliphatic ester suitable for use in surgical devices and a process for making said copolymer.


7
Han Cheng Zhang, William J Hoekstra, Bruce E Maryanoff, David F McComsey: Indole peptidomimetics as thrombin receptor antagonists. Ortho McNeil Pharmaceutical, Millennium Pharmaceuticals, Gabrial Lopez, Hal B Woodrow, February 22, 2005: US06858577 (16 worldwide citation)

The invention is directed to novel indole peptidomimetic compounds which are useful as thrombin receptor antagonists for the treatment of diseases associated with thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, Angi ...


8
Han Cheng Zhang, Bruce Maryanoff, Bruce Conway, Kimberly White, Hong Ye, Leonard Robert Hecker, David F McComsey: Indazolyl-substituted pyrroline compounds as kinase inhibitors. Ortho McNeil Pharmaceutical, Hal B Woodrow, Gabriel Lopez, February 1, 2005: US06849643 (12 worldwide citation)

The present invention is directed to novel indazolyl-substituted pyrroline compounds of Formula (I): useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.


9
David F McComsey, William J Hoekstra, Bruce E Maryanoff, Han Cheng Zhang: Indole and indazole urea-peptoids as thrombin receptor antagonists. Ortho McNeil Pharmaceutical, Hal B Woodrow, April 2, 2002: US06365617 (7 worldwide citation)

The invention is directed to novel indole and indazole urea-peptoid compounds which are useful as thrombin receptor antagonists for the treatment of diseases associated with thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic condi ...


10
Alfonzo Jordan, Allen B Reitz, Kevin Pan: 1,3,8-triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders. Hal B Woodrow, May 30, 2006: US07053101 (6 worldwide citation)

The present invention is directed to novel 1,3,8-triazaspiro[4.5]decan-4-one derivatives of the general formula wherein all variables are as defined herein, useful in the treatment of disorders and conditions mediated by the ORL-1 G-protein coupled receptor. More particularly, the compounds of the p ...